Raphael Pharmaceutical Inc.
RAPH
Rank in Stocks
#24796
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.51
Last synced: 2026-11-06
Market Cap
$30.47M
Change (1 day)
0.00%
Change (1 year)
51.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Raphael Pharmaceutical Inc. (RAPH)
Category
Healthcare
Number of shares outstanding for Raphael Pharmaceutical Inc. (RAPH)
Number of shares outstanding as of June 2026: 20.18M
According to Raphael Pharmaceutical Inc.'s latest financial reports, its current number of shares outstanding is 20.18M. At the end of 2025 the company had 19.55M shares outstanding. The number of shares outstanding usually changes with stock splits and share buybacks.
Shares outstanding history for Raphael Pharmaceutical Inc. (RAPH) from 2021 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 20.18M | 3.20% |
| 2025 | 19.55M | 4.70% |
| 2024 | 18.67M | 11.71% |
| 2023 | 16.72M | 16.56% |
| 2022 | 14.34M | -7.38% |
| 2021 | 15.48M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 434.78M | 2,054.88% |
DE
|
|
| 434.78M | 2,054.88% |
DE
|
|
| 1.56B | 7,644.57% |
JP
|
|
| 233.66M | 1,058.06% |
CH
|
|
| 1.17B | 5,679.02% |
IL
|
Questions about Raphael Pharmaceutical Inc.'s number of shares outstanding
What is Raphael Pharmaceutical Inc.'s number of shares outstanding?
Raphael Pharmaceutical Inc.'s number of shares outstanding is 20.18M, as of Jun 2026.
What was Raphael Pharmaceutical Inc.'s number of shares outstanding in 2025?
In 2025, Raphael Pharmaceutical Inc.'s number of shares outstanding was 19.55M, 4.70% more than in 2024 (18.67M).
How has Raphael Pharmaceutical Inc.'s number of shares outstanding changed since 2021?
From 2021 to 2025, Raphael Pharmaceutical Inc.'s number of shares outstanding went from 15.48M to 19.55M, an average growth of 6.00% a year.